ACTIVE

Apotheek Stabroek

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

32,1 k €

-58.8% YoY

Gross margin

385,9 k €

+0.3% YoY

Equity

-65,9 k €

+32.8% YoY

Workforce

3,8 ETP

-5.0% YoY

What does Apotheek Stabroek do?

Apotheek Stabroek is a Private limited company incorporated in 2015. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Stabroek. It employs on average 3,8 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0633.677.145

Incorporation

08/07/2015

Legal form

Private limited company

Registered office

Abtsdreef 12
2940 Stabroek · FlandreSee on map

Contributed capital

12 200,00 €

Latest accounts

31/12/2025

Average workforce

3,8 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores

Joint committees (3)

313
3130
313,00

Signals

ProfitableGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 10 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016
Income statement
Gross margin	385,9 k €	+0.3%	384,9 k €	+21.7%	316,2 k €	+36.6%	231,4 k €	+144%	95 k €	+1695%	-6 k €	+59.9%	-14,9 k €	-381%	-3,1 k €	+83.3%	-18,5 k €	-381%	-3,8 k €
EBITDA	100,7 k €	-30.5%	144,8 k €	+32.6%	109,2 k €	-8.5%	119,3 k €	+927%	-14,4 k €	+61.5%	-37,4 k €	-145%	-15,3 k €	-378%	-3,2 k €	+86.6%	-23,7 k €	-401%	-4,7 k €
Operating result	48,1 k €	-46.3%	89,5 k €	+59.3%	56,2 k €	-4.3%	58,7 k €	+178%	-75 k €	+16.5%	-89,7 k €	-174%	-32,7 k €	-192%	-11,2 k €	+64.8%	-31,7 k €	-89.7%	-16,7 k €
Net result	32,1 k €	-58.8%	78 k €	+60.7%	48,5 k €	-3.6%	50,3 k €	+156%	-89,2 k €	+9.8%	-98,9 k €	-167%	-37 k €	-195%	-12,6 k €	+61.5%	-32,6 k €	-94.5%	-16,8 k €
Balance sheet
Equity	-65,9 k €	+32.8%	-98 k €	+44.3%	-176 k €	+21.6%	-224,5 k €	+18.3%	-274,9 k €	-48.1%	-185,6 k €	-114%	-86,8 k €	-74.4%	-49,8 k €	-33.8%	-37,2 k €	-713%	-4,6 k €
Total assets	662,9 k €	+15.5%	573,7 k €	+4.1%	551,1 k €	+3.1%	534,3 k €	-4.5%	559,6 k €	+1.4%	551,8 k €	+157%	214,9 k €	+344%	48,4 k €	-18.8%	59,6 k €	-41.3%	101,5 k €
Cash	73,9 k €	+29.3%	57,2 k €	+89.9%	30,1 k €	-9.2%	33,2 k €	+4570%	710 €	-68.6%	2,3 k €	-97.2%	80,3 k €	+32066%	249,5 €	-98.6%	17,7 k €	+661%	2,3 k €
Debts	708,1 k €	+8.4%	653,2 k €	-8.1%	711,1 k €	-4.6%	745,5 k €	-9.6%	825,1 k €	+12.8%	731,3 k €	+146%	297,9 k €	+210%	96 k €	0.0%	96 k €	-9.5%	106,1 k €
Other
Workforce	3,8 ETP	-5.0%	4,0 ETP	+29.0%	3,1 ETP	+47.6%	2,1 ETP	+40.0%	1,5 ETP	+400%	0,3 ETP		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 4 ended

Active mandates

ORTEGAWYNTER

Director · since 08 juillet 2015 · 0501.597.490

Represented by Ortega SAEZ CARLOS

Active

TM Pharma

Director · since 08 juillet 2015 · 0881.130.182

Represented by Raemdonck MIEKE

Active

Ended mandates

ORTEGAWYNTER

Director · 0501.597.490

Represented by Carlos Ortega Saez

Ended

ORTEGAWYNTER

Manager · 0501.597.490

Represented by Carlos Ortega Saez

Ended

TM Pharma

Director · 0881.130.182

Represented by Mieke Raemdonck

Ended

TM Pharma

Manager · 0881.130.182

Represented by Mieke Raemdonck

Ended

At this address

Other companies at this address

Company	CBE no.
PROJECT STABROEK● Active	0736.769.438

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2026	03/07/2025	05/08/2024	20/07/2023	30/07/2022	29/06/2021
General meeting	22/06/2026	23/06/2025	17/06/2024	19/06/2023	20/06/2022	21/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

10 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	22/06/2026	29/06/2026	Dutch	PDF
Abridged model	31/12/2024	23/06/2025	03/07/2025	Dutch	PDF
Abridged model	31/12/2023	17/06/2024	05/08/2024	Dutch	PDF
Abridged model	31/12/2022	19/06/2023	20/07/2023	Dutch	PDF
Abridged model	31/12/2021	20/06/2022	30/07/2022	Dutch	PDF
Abridged model	31/12/2020	21/06/2021	29/06/2021	Dutch	PDF
Abridged model	31/12/2019	22/06/2020	25/06/2020	Dutch	PDF
Abridged model	31/12/2018	17/06/2019	24/06/2019	Dutch	PDF
Abridged model	31/12/2017	18/06/2018	19/06/2018	Dutch	PDF
Abridged model	31/12/2016	19/06/2017	13/07/2017	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 4 ended

Active mandates

ORTEGAWYNTER

Director · since 08 juillet 2015 · 0501.597.490

Represented by Ortega SAEZ CARLOS

Active

TM Pharma

Director · since 08 juillet 2015 · 0881.130.182

Represented by Raemdonck MIEKE

Active

Ended mandates

ORTEGAWYNTER

Director · 0501.597.490

Represented by Carlos Ortega Saez

Ended

ORTEGAWYNTER

Manager · 0501.597.490

Represented by Carlos Ortega Saez

Ended

TM Pharma

Director · 0881.130.182

Represented by Mieke Raemdonck

Ended

TM Pharma

Manager · 0881.130.182

Represented by Mieke Raemdonck

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates17/10/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - DIVERSEN - ONTSLAGEN - BENOEMINGEN
PDF
Registered office25/11/2020
MAATSCHAPPELIJKE ZETEL - WIJZIGING RECHTSVORM
PDF
Other13/07/2015
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202532,1 k €↓
2024
Annual accounts 202478 k €↑
2024
Name changeApotheek Stabroek
2023
Annual accounts 202348,5 k €↓
2022
Annual accounts 202250,3 k €↑
2021
Annual accounts 2021-89,2 k €↑
2020
Annual accounts 2020-98,9 k €↓
2019
Annual accounts 2019-37 k €↓
2018
Annual accounts 2018-12,6 k €↑
2017
Annual accounts 2017-32,6 k €↓
2016
Annual accounts 2016-16,8 k €
2016
Name changePharmazone
08/07/2015
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Apotheek Stabroek

Overview

What does Apotheek Stabroek do?

Trend over 10 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline